HYDERABAD: India’s first indigenous vaccine, Covaxin, managed to induce a robust immune response without any serious adverse events during phase 1 trials that were conducted on 375 volunteers, Bharat Biotech said in a research article. The company said that most of the adverse events seen during the study were mild …
Read More »Covaxin induced a robust immune response in phase 1 trials: Bharat Biotech | India News
